Israel Englander Madrigal Pharmaceuticals, Inc. Put Options Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$212.22 - $292.96 $530,550 - $732,400
2,500 Added 33.33%
10,000 $2.12 Million
Q2 2024

Aug 14, 2024
BUY
$193.33 - $291.99 $1.45 Million - $2.19 Million
7,500 New
7,500 $2.1 Million
Q4 2023

Feb 14, 2024
BUY
$120.4 - $237.13 $1.25 Million - $2.47 Million
10,400 New
10,400 $2.41 Million
Q4 2022

Feb 14, 2023
BUY
$58.39 - $296.54 $1.25 Million - $6.35 Million
21,400 Added 629.41%
24,800 $7.2 Million
Q3 2022

Nov 14, 2022
BUY
$60.57 - $79.51 $205,938 - $270,334
3,400 New
3,400 $221,000

Others Institutions Holding MDGL

# of Institutions
296
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.63B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email